FDA Drug Info Rounds, July 2012: Patents and Exclusivity

Описание к видео FDA Drug Info Rounds, July 2012: Patents and Exclusivity

Patents and exclusivity work in a similar fashion but are distinctly different from one another. Patents are granted by the patent and trademark office anywhere along the development lifeline of a drug and can encompass a wide range of claims. Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met. Exclusivity was designed to promote a balance between new drug innovation and generic drug competition. [vpdrugs]

Комментарии

Информация по комментариям в разработке

Похожие видео